Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injury
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injury
Authors
Keywords
-
Journal
DRUG DELIVERY
Volume 23, Issue 9, Pages 3520-3528
Publisher
Informa UK Limited
Online
2016-06-09
DOI
10.1080/10717544.2016.1199609
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CSF, blood-brain barrier, and brain drug delivery
- (2016) William M. Pardridge Expert Opinion on Drug Delivery
- A mouse model of weight-drop closed head injury: emphasis on cognitive and neurological deficiency
- (2016) Igor Khalin et al. Neural Regeneration Research
- Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness
- (2015) Igor Khalin et al. International Journal of Nanomedicine
- Neuroprotective Strategies for Traumatic Brain Injury: Improving Clinical Translation
- (2014) Shruti Kabadi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Post-Injury Treatment with 7,8-Dihydroxyflavone, a TrkB Receptor Agonist, Protects against Experimental Traumatic Brain Injury via PI3K/Akt Signaling
- (2014) Chun-Hu Wu et al. PLoS One
- Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
- (2013) Jörg Kreuter ADVANCED DRUG DELIVERY REVIEWS
- Functional Recovery after Transplantation of Neural Stem Cells Modified by Brain-Derived Neurotrophic Factor in Rats with Cerebral Ischaemia
- (2013) JM Zhu et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Animal models of traumatic brain injury
- (2013) Ye Xiong et al. NATURE REVIEWS NEUROSCIENCE
- GDNF, NGF and BDNF as therapeutic options for neurodegeneration
- (2013) Shelley J. Allen et al. PHARMACOLOGY & THERAPEUTICS
- From Molecular to Nanotechnology Strategies for Delivery of Neurotrophins: Emphasis on Brain-Derived Neurotrophic Factor (BDNF)
- (2013) Claire Géral et al. Pharmaceutics
- Protective Effects of BDNF Overexpression Bone Marrow Stromal Cell Transplantation in Rat Models of Traumatic Brain Injury
- (2012) Zhitao Wang et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Therapy Development for Diffuse Axonal Injury
- (2012) Douglas H. Smith et al. JOURNAL OF NEUROTRAUMA
- Uptake Mechanism of ApoE-Modified Nanoparticles on Brain Capillary Endothelial Cells as a Blood-Brain Barrier Model
- (2012) Sylvia Wagner et al. PLoS One
- Drug release from nanomedicines: selection of appropriate encapsulation and release methodology
- (2012) Stephanie J. Wallace et al. Drug Delivery and Translational Research
- Brain-Derived Neurotrophic Factor: A Dynamic Gatekeeper of Neural Plasticity
- (2012) Kiriana Cowansage et al. Current Molecular Pharmacology
- Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems
- (2011) Arati Sharma et al. Expert Opinion on Drug Metabolism & Toxicology
- Transport of drugs across the blood–brain barrier by nanoparticles
- (2011) Stefanie Wohlfart et al. JOURNAL OF CONTROLLED RELEASE
- Neural Stem Cells Over-Expressing Brain-Derived Neurotrophic Factor (BDNF) Stimulate Synaptic Protein Expression and Promote Functional Recovery Following Transplantation in Rat Model of Traumatic Brain Injury
- (2011) Haiying Ma et al. NEUROCHEMICAL RESEARCH
- Blood–Brain Barrier Pathophysiology in Traumatic Brain Injury
- (2011) Adam Chodobski et al. Translational Stroke Research
- Blood BDNF concentrations reflect brain-tissue BDNF levels across species
- (2010) Anders B. Klein et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Neural stem cells modified to express BDNF antagonize trimethyltin-induced neurotoxicity through PI3K/Akt and MAP kinase pathways
- (2010) Patrizia Casalbore et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution
- (2010) G. Tosi et al. JOURNAL OF CONTROLLED RELEASE
- Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: Influence of the formulation parameters
- (2009) Svetlana Gelperina et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Current advances in research and clinical applications of PLGA-based nanotechnology
- (2009) Jian-Ming Lü et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones
- (2009) Anja Zensi et al. JOURNAL OF CONTROLLED RELEASE
- Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles
- (2009) Kamila B. Kurakhmaeva et al. JOURNAL OF DRUG TARGETING
- Mouse closed head injury model induced by a weight-drop device
- (2009) Michael A Flierl et al. Nature Protocols
- Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease
- (2009) M. Blurton-Jones et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Estrogens and progesterone as neuroprotectants: what animal models teach us
- (2007) Meharvan Singh Frontiers in Bioscience-Landmark
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started